Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
12/19/2008
Trade Name:
Casodex
Generic or Proper Name (*):
bicalutamide
Indications Studied:
Gonadotropin-independent precocious puberty in boys with familial male-limited precocious puberty (testotoxicosis)
Therapeutic Category:
Androgen blocker
Ages Studied:
2 years and older
Study #:
1
Study Type:
Efficacy
Study Design:
Open Label/Active Control/Parallel Group
No Patients:
14
No Centers:
10
No Countries:
3
BPCA(B), PREA(P):
B
Asian:
0
Black:
1
Other:
1
White:
12
Native Hawaiian or Pacific Islander:
0
American Indian/Alaska Native:
0
Hispanic/Latino:
0
Non-Hispanic/Non Latino:
0
-
-